Small-molecule discovery

Our program began in November 2009 as part of the Ludwig Institute’s technology development program, which focuses on translating Ludwig discoveries into novel therapeutics for cancer patients. We are based at Ludwig San Diego, but our program supports scientific discoveries from the entire Ludwig community. We provide Ludwig scientists with chemical probes to accelerate basic and translational research, as well as create small-molecule medicines leveraging key Ludwig disease insights.